Point72 Asset Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-240,949
Closed -$1.53M 2197
2024
Q2
$1.53M Sell
240,949
-2,474,183
-91% -$19M ﹤0.01% 1166
2024
Q1
$25.2M Buy
2,715,132
+1,169,043
+76% +$13.7M 0.06% 375
2023
Q4
$19.7M Sell
1,546,089
-1,383,814
-47% -$14.4M 0.05% 433
2023
Q3
$30.3M Sell
2,929,903
-396,162
-12% -$4.59M 0.09% 296
2023
Q2
$43.6M Buy
3,326,065
+242,815
+8% +$2.97M 0.13% 200
2023
Q1
$34.5M Buy
3,083,250
+1,319,892
+75% +$13M 0.11% 236
2022
Q4
$14.9M Buy
1,763,358
+1,236,561
+235% +$11.8M 0.05% 421
2022
Q3
$8.78M Buy
526,797
+133,197
+34% +$2.45M 0.04% 538
2022
Q2
$5.79M Buy
393,600
+324,200
+467% +$6.68M 0.02% 664
2022
Q1
$1.72M Sell
69,400
-248,507
-78% -$6.42M 0.01% 893
2021
Q4
$10.2M Buy
317,907
+66,707
+27% +$2.44M 0.04% 506
2021
Q3
$9.04M Sell
251,200
-409,601
-62% -$16.1M 0.04% 515
2021
Q2
$29.2M Buy
660,801
+334,488
+103% +$14.6M 0.13% 202
2021
Q1
$14.9M Buy
326,313
+244,713
+300% +$14M 0.07% 330
2020
Q4
$5.63M Buy
+81,600
New +$4M 0.03% 562

Other funds holding LUNG

Point72 Asset Management's LUNG Position: Q3 2024 in Review

Point72 Asset Management sold out of Pulmonx (LUNG) in Q3 2024, closing a stake of 240,949 shares — an estimated $1.53M sold.

Point72 Asset Management first reported a position in LUNG in Q4 2020 and held it in 15 quarters. The position peaked at $43.6M in Q2 2023. 113 funds tracked by Wall St. Rank hold LUNG as of Q3 2024.

  • Point72 Asset Management reported no remaining Pulmonx position as of Q3 2024 after selling out during the quarter.
  • Point72 Asset Management sold 240,949 Pulmonx shares in Q3 2024, an estimated $1.53M.
  • Point72 Asset Management first reported a position in Pulmonx in Q4 2020 and held it in 15 quarters.
  • Point72 Asset Management's Pulmonx position peaked at $43.6M in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.